B. Sinués

1.0k total citations
35 papers, 874 citations indexed

About

B. Sinués is a scholar working on Pharmacology, Cancer Research and Oncology. According to data from OpenAlex, B. Sinués has authored 35 papers receiving a total of 874 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Pharmacology, 9 papers in Cancer Research and 8 papers in Oncology. Recurrent topics in B. Sinués's work include Pharmacogenetics and Drug Metabolism (15 papers), Carcinogens and Genotoxicity Assessment (9 papers) and Drug Transport and Resistance Mechanisms (8 papers). B. Sinués is often cited by papers focused on Pharmacogenetics and Drug Metabolism (15 papers), Carcinogens and Genotoxicity Assessment (9 papers) and Drug Transport and Resistance Mechanisms (8 papers). B. Sinués collaborates with scholars based in Spain, Sweden and Ecuador. B. Sinués's co-authors include Magnus Ingelman‐Sundberg, María Luisa Bernal, Mikael Oscarson, Roman A. McLellan, E Mayayo, M.L. Bernal, Hannu Raunio, Harriet Gullstén, Olavi Pelkonen and Arja Rautio and has published in prestigious journals such as FEBS Letters, Toxicology and Applied Pharmacology and The Journal of Strength and Conditioning Research.

In The Last Decade

B. Sinués

35 papers receiving 850 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
B. Sinués Spain 16 464 309 238 131 123 35 874
Tetsuya Kamataki Japan 16 589 1.3× 364 1.2× 273 1.1× 106 0.8× 68 0.6× 22 961
Harriet Gullstén Finland 8 517 1.1× 327 1.1× 200 0.8× 58 0.4× 77 0.6× 9 774
Masaki Fujieda Japan 19 506 1.1× 428 1.4× 312 1.3× 63 0.5× 44 0.4× 32 968
Saki Yamano Japan 8 519 1.1× 300 1.0× 288 1.2× 105 0.8× 111 0.9× 23 844
David R. Plowchalk United States 20 330 0.7× 270 0.9× 264 1.1× 149 1.1× 130 1.1× 27 1.4k
Catherine Spire France 12 370 0.8× 341 1.1× 193 0.8× 91 0.7× 75 0.6× 14 850
Peter Münzel Germany 22 553 1.2× 507 1.6× 397 1.7× 232 1.8× 211 1.7× 38 1.3k
Thierry Cresteil France 8 466 1.0× 280 0.9× 221 0.9× 78 0.6× 341 2.8× 13 1.1k
Roman A. McLellan Sweden 11 889 1.9× 489 1.6× 396 1.7× 78 0.6× 161 1.3× 13 1.3k
Ken‐ichi Nunoya Japan 15 336 0.7× 250 0.8× 254 1.1× 42 0.3× 100 0.8× 23 649

Countries citing papers authored by B. Sinués

Since Specialization
Citations

This map shows the geographic impact of B. Sinués's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B. Sinués with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B. Sinués more than expected).

Fields of papers citing papers by B. Sinués

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B. Sinués. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B. Sinués. The network helps show where B. Sinués may publish in the future.

Co-authorship network of co-authors of B. Sinués

This figure shows the co-authorship network connecting the top 25 collaborators of B. Sinués. A scholar is included among the top collaborators of B. Sinués based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B. Sinués. B. Sinués is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
González‐Andrade, Fabricio, et al.. (2014). Genetic polymorphisms of CYP2C8, CYP2C9 and CYP2C19 in Ecuadorian Mestizo and Spaniard populations: a comparative study. Molecular Biology Reports. 41(3). 1267–1272. 20 indexed citations
2.
Agúndez, José A. G., Francisco Abad‐Santos, Ana Aldea‐Perona, et al.. (2012). Toward a clinical practice guide in pharmacogenomics testing for functional polymorphisms of drug-metabolizing enzymes. Gene/drug pairs and barriers perceived in Spain. Frontiers in Genetics. 3. 273–273. 18 indexed citations
3.
González‐Andrade, Fabricio, et al.. (2011). Differences between Spaniards and Ecuadorians inCYP2A6allele frequencies: comparison with other populations. Fundamental and Clinical Pharmacology. 25(5). 627–632. 6 indexed citations
4.
Vásquez, Patricia, et al.. (2009). Haplotype structure and allele frequencies ofCYP2B6in Spaniards and Central Americans. Fundamental and Clinical Pharmacology. 24(2). 247–253. 15 indexed citations
5.
Sinués, B., et al.. (2008). CYP3A5*3, CYP3A4*1B and MDR1 C3435T Genotype Distributions in Ecuadorians. Disease Markers. 24(6). 325–331. 6 indexed citations
6.
Sinués, B., et al.. (2007). Polymorphism C3435T of the MDR1 gene in Central Americans and Spaniards. Molecular Biology Reports. 35(3). 473–478. 11 indexed citations
7.
Sinués, B., et al.. (2007). CYP3A5*3 and CYP3A4*1B Allele Distribution and Genotype Combinations: Differences Between Spaniards and Central Americans. Therapeutic Drug Monitoring. 29(4). 412–416. 29 indexed citations
8.
Sinués, B., et al.. (2007). Growth Hormone Does Not Alter CYP2A6 Activity in Growth Hormone‐Deficient Children. Basic & Clinical Pharmacology & Toxicology. 102(1). 45–49. 1 indexed citations
9.
Sinués, B., et al.. (2006). Lack of effect of growth hormone replacement therapy on CYP1A2 and xanthine oxidase activities in growth hormone–deficient children. European Journal of Clinical Pharmacology. 62(2). 123–127. 10 indexed citations
10.
Oscarson, Mikael, et al.. (2002). Characterization of a novelCYP2A7/CYP2A6 hybrid allele (CYP2A6*12) that causes reduced CYP2A6 activity. Human Mutation. 20(4). 275–283. 77 indexed citations
11.
Gilaberte, Yolanda, et al.. (1999). Antioxidant Intracellular Activity of Genistein and Equol. Journal of Medicinal Food. 2(3-4). 253–256. 5 indexed citations
12.
Oscarson, Mikael, Roman A. McLellan, Harriet Gullstén, et al.. (1999). Characterisation and PCR‐based detection of a CYP2A6 gene deletion found at a high frequency in a Chinese population. FEBS Letters. 448(1). 105–110. 182 indexed citations
13.
Oscarson, Mikael, Harriet Gullstén, Arja Rautio, et al.. (1998). Genotyping of human cytochrome P450 2A6 (CYP2A6), a nicotine C‐oxidase. FEBS Letters. 438(3). 201–205. 130 indexed citations
14.
Sinués, B., et al.. (1995). Six mutagenicity assays in exposure biomonitoring of patients receiving carbamazepine for epilepsy or trigeminal neuralgia. Mutation Research/Environmental Mutagenesis and Related Subjects. 334(2). 259–265. 13 indexed citations
15.
Huerva, Valentín, et al.. (1993). Levels of Vancomycin in Aqueous Humor After Topical Eye Drops Administration. Journal of Ocular Pharmacology and Therapeutics. 9(2). 167–170. 18 indexed citations
16.
Sinués, B., et al.. (1992). Cytogenetic study in peripheral blood lymphocytes from asthmatic patients receiving continued therapy with theophylline. Mutation Research/Genetic Toxicology. 280(4). 271–277. 4 indexed citations
17.
Sinués, B., A. Sanz, M.L. Bernal, et al.. (1991). Sister chromatid exchanges, proliferating rate index, and micronuclei in biomonitoring of internal exposure to vinyl chloride monomer in plastic industry workers. Toxicology and Applied Pharmacology. 108(1). 37–45. 25 indexed citations
18.
Sinués, B., et al.. (1991). Micronucleus assay in biomonitoring of patients undergoing excretory urography with diatrizoate and ioxaglate. Mutation Research/Genetic Toxicology. 260(4). 337–342. 19 indexed citations
19.
Sinués, B., et al.. (1990). Chromosome aberrations and urinary thioethers in smokers. Mutation Research/Genetic Toxicology. 240(4). 289–293. 25 indexed citations
20.
Sinués, B., et al.. (1990). Cytogenic Effects of Diatrizoate and Ioxaglate on Patients Undergoing Excretory Urography. Investigative Radiology. 25(6). 692–697. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tetsuya Kamataki Breakdown of academic impact, for papers by Harriet Gullstén Breakdown of academic impact, for papers by Masaki Fujieda Breakdown of academic impact, for papers by Saki Yamano Breakdown of academic impact, for papers by David R. Plowchalk Breakdown of academic impact, for papers by Catherine Spire Breakdown of academic impact, for papers by Peter Münzel Breakdown of academic impact, for papers by Thierry Cresteil Breakdown of academic impact, for papers by Roman A. McLellan Breakdown of academic impact, for papers by Ken‐ichi Nunoya
Rankless by CCL
2026